Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain

Human Psychopharmacology

Volumn 18, Issue 6, 2003, Pages 457-461

  Atmaca, Murad ^a   Kuloglu, Murat ^a   Tezcan, Ertan ^a   Ustundag, Bilal ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Leptin; Nizatidine; Olanzapine; Weight gain

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; LEPTIN; NEUROLEPTIC AGENT; NIZATIDINE; OLANZAPINE; PLACEBO; RISPERIDONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEADACHE; HORMONE BLOOD LEVEL; HUMAN; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; LEPTIN; MALE; NIZATIDINE; OBESITY; PIRENZEPINE; SCHIZOPHRENIA; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0042425850     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.514     Document Type: Article

References (34)

1. Allison DB, Mentore JL, Heo M, et al. 1999. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 56: 1686-1696.
2. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Department of Psychiatry College of Medicine, The University of Iowa: Iowa.
3. Andreasen NC. 1984. Scale for the Assessment of Positive Symptoms (SAPS). Department of Psychiatry College of Medicine, The University of Iowa: Iowa.
4. Atmaca M, Kuloglu M, Tezcan E, Gecici O, Ustundag B. 2002a. Serum cholesterol and leptin levels in patients with borderline personality disorder. Neuropsychobiology 45: 167-171.
5. Atmaca M, Kuloglu M, Tezcan E, Semercioz A, Ustundag B, Ayar A. 2002b. Serum leptin levels in the patients with premature ejaculation. Arch Andrology 48: 345-350.
6. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. 2002. Weight gain and serum leptin levels in patients on lithium treatment. Neuropsychobiology 46: 67-69.
7. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O. 2003. Weight gain, serum leptin and triglyceride levels in the patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol. Schizophr Res 60: 99-100.
8. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B. 2002e. Serum leptin and cholesterol values in the suicide attempters. Neuropsychobiology 45: 124-127.
9. Auwerx J, Steals B. 1998. Leptin. Lancet 351: 737-742.
10. Baptista T, Lacruz A, de Mendoza S, et al. 2000. Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 33: 81-88.
11. Brady T. 1989. Weight gain associated with psychotropic drugs. South Med J 82: 611-617.
12. Calapai G, Corica F, Corsonello A, et al. 1999. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest 104: 975-982.
13. Considine RV, Caro JF. 1997. Leptin and the regulation of body weight. Int J Biochem Cell Biol 29: 1255-1272.
14. De Vry J, Schreiber H. 2000. Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior: possible mechansisms of action. Neurosci Biobehav Rev 24: 341-353.
15. Dryden S, Brown M, King P, Williams G. 1999. Decreased plasma leptin levels in lean and obses Zucker rate after treatment with the serotonin reuptake inhibitor fluoxetine. Horm Metab Res 31: 363-366.
16. Gibbs J, Young RC, Smith GP. 1973. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495.
17. Halaas JL, Gajiwala KS, Maffei M, et al. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546.
18. Kraus T, Haack M, Schuld A, et al. 1999. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156: 312-314.
19. Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. 2001. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinolgy 73: 243-247.
20. Liebowitz SF, Alexander JT. 1998. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 44: 851-864.
21. Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jemerson DC. 1997. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab 82: 1845-1851.
22. McIntyre RS, Mancini DA, Basile VS. 2001. Mechanisms of antipsychotic-induced weights gain. J Clin Psychiatry 62: 23-29.
23. Meguid MM, Fetissov SO, Varma M, et al. 2000. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16: 843-857.
24. Melkersson KI, Hulting AL, Brismar KE. 2000. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 16: 742-749.
25. Morimoto T, Yamamoto Y, Mobarakeh JI, Yanai K, Watanabe T, Yamatadoni A. 1999. Involvement of the histaminergic system in leptin-induced suppression of food intake. Physiol Behav 67: 679-683.
26. Morimoto T, Yamamoto Y, Yamatodani A. 2000. Leptin facilitates histamine release from the hypothalamus in rats. Brain Res 868: 367-369.
27. Osser DN, Najarian DM, Dufresne RL. 1999. Olanzapine increases weight and serum triglyceride levels. J Clin Psychiatry 60: 767-770.
28. Richelson E. 1996. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry 57: 4-11.
29. 2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biol Psychiatry 48: 167-168.
30. Stahl SM. 1998. Neuropharmacology of obesity: my receptors made me cat it. J Clin Psychiatry 59: 447-448.
31. Stoa-Birkedvedt G, Paus PN, Ganss R, Florholmen J. 1996. Cimetidine reduces weight and improves metabolic control in type II diabetes mellitus. Diabetes 45: 122.
32. Stoa-Birkedvedt G, Paus PN, Ganss R, Ingebretsen OC, Florholmen J. 1998. Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes. Int J Obes Relat Metab Disord 22: 1041-1045.
33. 2c serotonin receptors. Nature 374: 542-546.
34. Wang L, Barachina MD, Martinez Y, Wei JY, Tache Y. 2000. Synergistic interaction between CCK and leptin to regulate food intake. Regul Pept 92: 79-85.